Recombinant Anti-IL1α x Anti-IL1β Bispecific Antibody (CrossMab) (CROSSAB-177)

Recombinant Anti-IL1α x Anti-IL1β Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Osteoarthritis (OA) therapy.

Datasheet INQUIRY

Specifications

Targets

IL1α & IL1β

Type

CrossMab

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Osteoarthritis (OA)

Targets

Target 1

IL1α

Gene ID

3552

UniProt ID

P01583

Alternative Names

IL1; IL-1A; IL1F1; IL1-ALPHA; Interleukin 1 alpha; hematopoietin 1; IL1α

Target 2

IL1β

Gene ID

3553

UniProt ID

P01584

Alternative Names

IL-1; IL1F2; IL1-BETA; IL1β; Interleukin-1β; IL-1β

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL1α x Anti-IL1β Bispecific Antibody (CrossMab) (CROSSAB-177). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL1α x Anti-IL1β Bispecific Antibody (CrossMab) (CAT#: CROSSAB-177)

Specifications

Targets

Customer Reviews and Q&As